Literature DB >> 20825265

Olfactory dysfunction in schizophrenia: a review of neuroanatomy and psychophysiological measurements.

An D Nguyen1, Martha E Shenton, James J Levitt.   

Abstract

Olfactory processing is thought to be mediated via the frontal and temporolimbic brain regions, both of which, as well as olfactory dysfunction, are implicated in schizophrenia. Likewise, several empirical studies of olfactory dysfunction--in particular, olfactory deficits in identification, odor detection threshold sensitivity, and odor memory, along with associated brain structural changes--have been conducted to illuminate the pathophysiology of schizophrenia. These anomalies have been investigated, more recently, as possible biological markers of that disabling illness. This article summarizes recent research on neuroimaging changes associated with olfactory impairments in schizophrenia patients and on related functional changes in psychophysiological measurements (e.g., odor identification, odor discrimination, odor detection threshold, and odor memory). The possible role of these changes as biological markers of the disorder will be discussed, as will potentially productive directions for future research.

Entities:  

Mesh:

Year:  2010        PMID: 20825265     DOI: 10.3109/10673229.2010.511060

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  20 in total

1.  The olfactory function is impaired in patients with idiopathic inflammatory myopathies.

Authors:  L Iaccarino; N Shoenfeld; M Rampudda; M Zen; M Gatto; A Ghirardello; N Bassi; L Punzi; Y Shoenfeld; A Doria
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Olfaction in child and adolescent anorexia nervosa.

Authors:  Martin Schecklmann; Christoph Pfannstiel; Andreas J Fallgatter; Andreas Warnke; Manfred Gerlach; Marcel Romanos
Journal:  J Neural Transm (Vienna)       Date:  2011-12-20       Impact factor: 3.575

3.  Smell identification function in children with attention deficit hyperactivity disorder.

Authors:  Ahmad Ghanizadeh; Maryam Bahrani; Ramin Miri; Ali Sahraian
Journal:  Psychiatry Investig       Date:  2012-04-30       Impact factor: 2.505

4.  Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.

Authors:  Mary R Lee; Heidi J Wehring; Robert P McMahon; Jared Linthicum; Nicola Cascella; Fang Liu; Alan Bellack; Robert W Buchanan; Gregory P Strauss; Carlo Contoreggi; Deanna L Kelly
Journal:  Schizophr Res       Date:  2013-02-13       Impact factor: 4.939

5.  N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice.

Authors:  David-Marian Otte; Britta Sommersberg; Alexei Kudin; Catalina Guerrero; Onder Albayram; Michaela D Filiou; Pamela Frisch; Oznur Yilmaz; Eva Drews; Christoph W Turck; Andras Bilkei-Gorzó; Wolfram S Kunz; Heinz Beck; Andreas Zimmer
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

6.  NKCC1 knockdown decreases neuron production through GABA(A)-regulated neural progenitor proliferation and delays dendrite development.

Authors:  Stephanie Z Young; M Morgan Taylor; Sharon Wu; Yuri Ikeda-Matsuo; Cathryn Kubera; Angélique Bordey
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

Review 7.  Adult neurogenesis and mental illness.

Authors:  Timothy J Schoenfeld; Heather A Cameron
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

Review 8.  New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction.

Authors:  Howard J Hoffman; Shristi Rawal; Chuan-Ming Li; Valerie B Duffy
Journal:  Rev Endocr Metab Disord       Date:  2016-06       Impact factor: 6.514

9.  Assessing olfactory, memory, social and circadian phenotypes associated with schizophrenia in a genetic model based on Rim.

Authors:  Sergio Hidalgo; Jorge M Campusano; James J L Hodge
Journal:  Transl Psychiatry       Date:  2021-05-17       Impact factor: 6.222

10.  Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia.

Authors:  Steven M Silverstein; Yushi Wang; Brian P Keane
Journal:  Front Psychol       Date:  2013-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.